BU-NOT-SET

CONTACT US
Identifying impurities using advanced analytics
  • Analytical chemistry
Eyes
Insight
Recipharm on the impact of COVID-19 on API supply
  • Industry trends
Eyes
Insight
The role of excipient selection in the development of orally disintegrating tablets
  • Drug product
Eyes
Insight
Solving analytical method challenges to advance animal antibiotic
  • Analytical chemistry
Hand vial stand
Case study
The outlook for a year of change
  • Industry trends
Eyes
Insight
Can oral solid dose keep its place as the leading dosage form?
  • Drug product
Eyes
Insight
Relocating API supply to avoid over-reliance
  • Drug substance
Eyes
Insight
Modified release fixed dose combination product with two poorly soluble drug substances
  • Drug product
pellets
Case study
Patient centricity during drug development and commercialisation
  • Drug product
Eyes
Insight
Insight
  • Drug substance
The oncolytic efficacy and in vivo pharmacokinetics of [2-(4- Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) are governed by distinct stereochemical features
Insight
  • Manufacturing
Strategies to prepare for serialisation
Insight
  • Drug substance
A Versatile One-Pot Procedure for the Synthesis of 5-Aryl-6H- 1,3,4-thiadiazine-2-amines from Aromatic Ketones